Mitchell Mcleod Pugh & Williams Inc Bristol Myers Squibb CO Transaction History
Mitchell Mcleod Pugh & Williams Inc
- $479 Million
- Q1 2025
A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 14,401 shares of BMY stock, worth $719,617. This represents 0.18% of its overall portfolio holdings.
Number of Shares
14,401
Previous 11,353
26.85%
Holding current value
$719,617
Previous $642,000
36.76%
% of portfolio
0.18%
Previous 0.14%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.56 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.93 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.4 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.74 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.32 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...